Top Markets
Coin of the day
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
Rank in Stocks #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
Share Price
$0.85
Last synced: 2025-01-21
Market Cap
$411.40
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Fresh2 Group Limited (FRES)

Category

P/E ratio for Fresh2 Group Limited (FRES)
P/E ratio as of August 2026 TTM: 0.00
According to Fresh2 Group Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0.00. At the end of 2021 the company had a P/E ratio of 0.00.
P/E ratio history for Fresh2 Group Limited from 2017 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 0.00 -33.33%
2022 0.00 -33.33%
2021 0.00 -82.28%
2020 -0.03 -36.18%
2019 -0.04 -56.17%
2018 -0.09 -7.82%
2017 -0.10 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
28.05 -28,048,300.00%
US
31.14 -31,144,300.00%
NL
- -
CH
19.30 -19,298,800.00%
BE
- -
KR
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.